Related Experiment Videos
Self-oxidatively crosslinked sprayable hydrogel for microenvironment remodeling and accelerated healing of recurrent
Lihong Zhou1,2, Jingyu Yan1,2, Yurong Xu1,2
1Shanxi Medical University School and Hospital of Stomatology, Taiyuan, Shanxi, 030001, China.
Abstract:
Recurrent aphthous ulcer (RAU) is a prevalent inflammatory disorder of the oral mucosa, characterized by a persistent "vicious cycle" of excessive oxidative stress, dysregulated immune responses, and impaired tissue regeneration. Effective clinical management remains challenging due to the dynamic and hydrated oral environment, which severely limits drug retention and multi-target therapeutic efficacy. Herein, we developed a multifunctional, sprayable hydrogel (PDS Gel) using a hierarchical "oxygen-limited initiation - oxygen-controlled progression" crosslinking strategy, integrating polygalacturonic acid (PGA), dopamine (DA), and salidroside-derived carbon dots (Sal-CDs). The PDS Gel achieves rapid in situ solidification and exhibits certain mucoadhesive properties, allowing attachment to the wet mucosal surface shortly after spraying. Mechanistically, the hydrogel exhibits potent reactive oxygen species (ROS) scavenging capacity and intrinsic antibacterial activity, effectively remodeling the pathological wound microenvironment. Crucially, PDS Gel promotes macrophage polarization from a pro-inflammatory M1 phenotype toward a pro-regenerative M2 phenotype, thereby suppressing excessive inflammatory cascades. Simultaneously, it restores fibroblast-mediated extracellular matrix (ECM) remodeling and enhances endothelial cell-driven angiogenesis. In vivo evaluations using both oral mucosal and full-thickness skin defect models demonstrate that PDS Gel significantly accelerates wound closure, facilitates epithelial reconstruction, and promotes orderly collagen deposition. Collectively, this self-oxidatively crosslinked immunomodulatory hydrogel provides a promising biomaterial paradigm for the precision therapy of RAU and other complex mucosal lesions.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...